Poxel S.A.
0RA2.L
Poxel S.A., a clinical-stage biopharmaceutical company, develops novel treatments for metabolic diseases, type 2 diabetes, and liver diseases. The company's lead product is TWYMEEG (Imeglimin), an oral drug candidate that targets mitochondrial dysfunction and approved for the treatment of type 2 diabetes in Japan. It also develops PXL770, an adenosine monophosphate-activated protein kinase enzyme, which is in a Phase 2a clinical trial that treats chronic metabolic diseases, including diseases that affect the liver, such as non-alcoholic steatohepatitis (NASH). Poxel S.A. has a licensing agreement with Enyo Pharma S.A.S. for the development of farnesoid X receptor that is in Phase 2a study fo...[Read more]
Industry
Biotechnology
IPO Date
2016-02-03
Stock Exchange
LSE
Ticker
0RA2.L
PE Ratio
[-1.93]
ROE
[104.21%]
Current Ratio
[0.34]
Dividend Yield
[0%]
Enterprise Value
[57.55M]
Dividend History
The ROE as of November 2025 (TTM) for Poxel S.A. (0RA2.L) is 104.21%
According to Poxel S.A.’s latest financial reports and current stock price. The company's current ROE is 104.21%. This represents a change of 115.21% compared to the average of 48.42% of the last 4 quarters.
Poxel S.A. (0RA2.L) Historical ROE (quarterly & annually)
How has 0RA2.L ROE performed in the past?
The mean historical ROE of Poxel S.A. over the last ten years is 13.58%. The current 104.21% ROE has changed 667.32% with respect to the historical average. Over the past ten years (40 quarters), 0RA2.L's ROE was at its highest in in the June 2022 quarter at 372.87%. The ROE was at its lowest in in the December 2012 quarter at -1132.96%.
Average
13.58%
Median
-47.18%
Minimum
-289.57%
Maximum
552.79%
Poxel S.A. (0RA2.L) ROE by Quarter and Year
Discovering the peaks and valleys of Poxel S.A. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 440.83%
Maximum Annual ROE = 552.79%
Minimum Annual Increase = -371.25%
Minimum Annual ROE = -289.57%
| Year | ROE | Change |
|---|---|---|
| 2023 | 71.46% | -58.49% |
| 2022 | 172.13% | -159.44% |
| 2021 | -289.57% | 146.00% |
| 2020 | -117.71% | 78.98% |
| 2019 | -65.77% | -371.25% |
| 2018 | 24.25% | -120.65% |
| 2017 | -117.42% | 88.90% |
| 2016 | -62.16% | 93.11% |
| 2015 | -32.19% | -105.82% |
| 2014 | 552.79% | 440.83% |
Poxel S.A. (0RA2.L) Average ROE
How has 0RA2.L ROE performed in the past?
The current ROE of Poxel S.A. (0RA2.L) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages
3-year avg
-15.33%
5-year avg
-45.89%
10-year avg
13.58%
Poxel S.A. (0RA2.L) ROE vs. Peers
How is 0RA2.L’s ROE compared to its peers?
Poxel S.A.’s ROE is
| Company | ROE | Market cap |
|---|
Build a custom stock screener for Poxel S.A. (0RA2.L) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Poxel S.A. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Poxel S.A. (0RA2.L) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Poxel S.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Poxel S.A.'s ROE?
How is the ROE calculated for Poxel S.A. (0RA2.L)?
What is the highest ROE for Poxel S.A. (0RA2.L)?
What is the 3-year average ROE for Poxel S.A. (0RA2.L)?
What is the 5-year average ROE for Poxel S.A. (0RA2.L)?
How does the current ROE for Poxel S.A. (0RA2.L) compare to its historical average?